Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00708305 · ClinicalTrials.gov registry record · Phase 3

Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes

A Phase 3 study, sponsored by GlaxoSmithKline.

Completed
Registry status
Phase 3
Development phase
65
Enrollment target

NCT00708305 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 65 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00708305, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
Phase 3
Development phase
65 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the efficacy of different sodium fluoride (NaF) containing toothpastes in prevention of dental caries. Change from baseline fluoride data at various time points up to four hours after a single brushing with NaF containing toothpastes will be evaluated.

Interventions

  • DRUG Placebo
  • DRUG Sodium Fluoride (NaF)

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2008-06
Est. Completion 2008-10
Phase Phase 3

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT00708305

The ClinicalTrials.gov registry entry for NCT00708305 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00708305 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00708305 about?

NCT00708305 is a clinical study titled "Evaluation of Plaque Fluid Fluoride Retention From Fluoride Toothpastes". The purpose of this study is to investigate the efficacy of different sodium fluoride (NaF) containing toothpastes in prevention of dental caries. Change from baseline fluoride data at various time points up to four hours after a single brushing with NaF containing toothpastes will be evaluated.

What is the current status of trial NCT00708305?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 65 participants. The study started on 2008-06. Estimated completion is 2008-10.

What interventions are being tested in trial NCT00708305?

The interventions under investigation include: Placebo (DRUG), Sodium Fluoride (NaF) (DRUG).

Who is sponsoring clinical trial NCT00708305?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.